浙江水晶光电科技股份有限公司 第六届董事会薪酬与考核委员会 计报告； 审计报告； 形； 公司具备实施股权激励计划的主体资格。 二、本激励计划的激励对象不存在《管理办法》规定的不得成为激励对象的以下情形： 市场禁入措施； 关于公司 2025 年限制性股票激励计划相关事项的核查意见 浙江水晶光电科技股份有限公司（以下简称"公司"）第六届董事会薪酬与考核委员会 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、 《上市公司股权激励管理办法》 （以下简称"《管理办法》"） 等相关法律法规、规范性文件和《公司章程》的有关规定，对公司《2025 年限制性股票激 励计划（草案）》（以下简称"《激励计划（草案）》"或"本激励计划"）及其相关事项 进行了核查，发表核查意见如下： 一、公司不存在《管理办法》等法律法规、规范性文件规定的禁止实施股权激励计划的 下列情形： 综上所述，我们同意公司实施本次激励计划。 浙江水晶光电科技股份有限公司第六届董事会 薪酬与考核委员会 ［本页无正文，为第六届董事会薪酬与考核委员会关于公司 2025 年限制性股票激励计划相 关事项的核查意 ...

Core Viewpoint - The legal opinion letter from Beijing Zhonglun Law Firm confirms that Shanghai Suochen Information Technology Co., Ltd. is eligible to implement its 2025 restricted stock incentive plan, adhering to relevant laws and regulations [2][4][21]. Group 1: Company Overview - Company Name: Shanghai Suochen Information Technology Co., Ltd. [8] - Unified Social Credit Code: 91310000785643574Y [8] - Registered Capital: 89.108784 million yuan [8] - Established Date: February 24, 2006 [8] - Company Type: Joint-stock company (listed, natural person investment or control) [8] Group 2: Incentive Plan Details - The incentive plan involves granting up to 693,511 restricted stocks, accounting for approximately 0.7783% of the company's total share capital [12]. - The first grant will consist of 554,809 restricted stocks, representing about 0.6226% of the total share capital [12]. - The plan includes provisions for the management of the incentive program, including eligibility criteria, stock allocation, and vesting conditions [11][16]. Group 3: Legal Compliance and Procedures - The company has fulfilled necessary legal procedures for the implementation of the incentive plan, including board and supervisory committee approvals [17][21]. - The plan has been reviewed and approved by the remuneration and assessment committee, which believes it will benefit the company's sustainable development [23]. - The company has committed not to provide financial assistance to the incentive plan participants [21][23]. Group 4: Impact on Shareholders - The incentive plan is designed to align the interests of the incentive recipients with those of the shareholders, ensuring no significant harm to shareholder interests [23][24]. - The plan's procedures have been established to maintain transparency and protect shareholder rights [23][24].

证券代码：688619 证券简称：罗普特 公告编号：2025-039 罗普特科技集团股份有限公司 罗普特科技集团股份有限公司（以下简称"公司"）于 2024 年 7 月 4 日召 开 2024 年第一次临时股东大会，审议通过了《关于 <公司 ensp="ensp" 年限制性股票激="年限制性股 票激"> 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 励计划（草案）>及其摘要的议案》（以下简称"本激励计划"）。本激励计划 中规定的预留授予第二类限制性股票数量为 322,500 股，占本激励计划拟授予 权益总数的比例为 20%。预留权益（322,500 股）因未在 2024 年第一次临时股 东大会通过本次激励计划后 12 个月内明确激励对象而失效。现将有关事项说明 如下： 一、 2024 年限制性股票激励计划已履行的决策程序和信息披露情况 了《关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要 的议案》《关于 <公司 ensp="ensp" 年限制性股票激励计划实施考 ...

Core Points - The announcement details the results of the third exercise period for the stock option incentive plan of Shanghai Pharmaceuticals, indicating that no options were exercised during the second quarter of 2025 [4][11] - The total number of stock options available for the third exercise period is 680,000, with the exercise period running from February 8, 2025, to February 7, 2026 [4][11] - The company has followed all necessary approval procedures for the stock option incentive plan, including independent opinions from directors and the supervisory board [2][3][5] Approval Process - The company’s board approved the stock option incentive plan and its management measures, with independent directors providing their opinions and the supervisory board conducting necessary checks [2][3][5] - The plan was initially approved by the State-owned Assets Supervision and Administration Commission [1][2] Exercise Details - As of the second quarter of 2025, the number of individuals eligible to exercise the options is 20, but none have exercised their options [7][11] - The stock options are to be issued as ordinary shares (A-shares) to the incentive targets [7][9] Impact on Financials - The lack of exercised options during the third exercise period has not had a significant impact on the company's financial status or operating results as of the end of the second quarter of 2025 [11]

Core Viewpoint - The company is set to implement a restricted stock incentive plan for 2025, which aims to attract and retain talent while aligning the interests of shareholders, the company, and core team members [1][4]. Group 1: Eligibility and Compliance - The company meets the qualifications to implement the stock incentive plan and does not fall under any prohibitive conditions outlined in relevant laws and regulations [1][3]. - The incentive plan's participants do not include independent directors, supervisors, or shareholders holding more than 5% of the company's shares [1][2]. Group 2: Incentive Plan Details - The plan includes an international participant, Mao Dan yun, who is the Vice President and leads the R&D department, contributing significantly to the company's technological advancements [2]. - The plan's design and review process comply with the relevant laws and regulations, ensuring that the granting and vesting arrangements do not violate any legal provisions [3][4]. Group 3: Benefits of the Incentive Plan - Implementing the restricted stock incentive plan will help establish a long-term incentive mechanism, motivating core management and key personnel, thereby supporting the company's long-term development [4].

Group 1 - The core viewpoint of the news is that the Supervisory Board of Jebon Precision Technology Co., Ltd. has verified the eligibility of 64 individuals for the first vesting period of the restricted stock and stock options under the 2024 incentive plan, confirming compliance with relevant laws and regulations [1][2] - The first vesting conditions for the restricted stock have been met, allowing for the allocation of 266,700 shares to the eligible individuals [1] - The first exercise conditions for the stock options have also been met, permitting the exercise of 266,700 stock options for the eligible individuals [2] Group 2 - The verification process for both the restricted stock and stock options adheres to the provisions of the Company Law, Securities Law, and the Management Measures for Incentive Plans, ensuring no harm to the interests of the company and its shareholders [1][2] - The eligibility criteria for the incentive plan participants have been confirmed, with all 64 individuals meeting the necessary qualifications as per the relevant regulations [1][2]

证券代码：301332 证券简称：德尔玛 公告编号：2025-029 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 广东德尔玛科技股份有限公司（以下简称"公司"或"德尔玛"）于 2025 年 7 月 4 日召开第二届董事会第十次会议和第二届监事会第十次会议，审议通过 了《关于调整公司 2024 年限制性股票激励计划授予价格的议案》，现将有关事 项公告如下： 一、已履行的决策程序和信息披露情况 （一）2024 年 7 月 12 日，公司召开第二届董事会第四次会议，会议审议通 过了《关于公司〈2024 年限制性股票激励计划（草案）〉及其摘要的议案》《关 于公司〈2024 年限制性股票激励计划实施考核管理办法〉的议案》及《关于提 请股东大会授权董事会办理公司 2024 年限制性股票激励计划相关事宜的议案》 等。相关议案已经董事会薪酬与考核委员会审议通过。 （二）2024 年 7 月 12 日，公司召开第二届监事会第四次会议，会议审议通 过了《关于公司〈2024 年限制性股票激励计划（草案）〉及其摘要的议案》《关 于公司〈2024 年限制性股票激励计划实施考核管理办 ...

Group 1 - The company is adjusting the repurchase price and canceling part of the granted restricted stock under its 2021 incentive plan, following necessary legal procedures and approvals [11][12][18] - The repurchase price adjustment is based on the company's profit distribution and capital changes, ensuring compliance with relevant regulations [12][17] - The company plans to repurchase a total of 585.344 million shares of restricted stock due to unmet performance targets for the third unlock period [14][16] Group 2 - The repurchase price for the restricted stock is set at 6.36 yuan per share, plus bank interest, with a total funding requirement of approximately 37.782 million yuan sourced from the company's own funds [16][17] - The company has obtained necessary approvals for the repurchase and cancellation of restricted stock, but still needs to fulfill shareholder meeting procedures and regulatory disclosures [18]

证券代码：000830 证券简称：鲁西化工 公告编号：2025-048 鲁西化工集团股份有限公司 关于2021年限制性股票激励计划第三个解除限售期解除限 售条件未成就并回购注销部分限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 鲁西化工集团股份有限公司（以下简称"本公司"或"公司"） 于2025年7月3日召开的第九届董事会第十次会议、第九届监事会 第四次会议审议通过了《关于2021年限制性股票激励计划第三个 解除限售期解除限售条件未成就并回购注销部分限制性股票的 议案》，根据《鲁西化工集团股份有限公司2021年限制性股票激 励计划（草案修订稿）》（以下简称"《激励计划》"或"《本 激励计划》"）及《上市公司股权激励管理办法》 （以下简称"《管 理办法》"）的规定，5名首次授予激励对象因发生《激励计划》 "第十三章 公司/激励对象发生异动的处理"之"二、激励对象 个人情况发生变化"第四项规定，不具备激励资格；公司第三个 解除限售期解除限售条件未达成，公司拟回购注销部分尚未解除 限售的限制性股票。现对有关事项说明如下： 一、本次股权激励计划已履行 ...

证券代码：603709 证券简称：中源家居 公告编号：2025-031 中源家居股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据中国证券监督管理委员会《上市公司股权激励管理办法》、上海证券交易 所及中国证券登记结算有限责任公司上海分公司（以下简称"中登公司上海分公 司"）有关规定，中源家居股份有限公司（以下简称"公司"）于近日在中登公司 上海分公司办理完成公司 2024 年限制性股票激励计划（以下简称"本激励计划"） 的预留授予登记工作，现就有关事项公告如下： 一、限制性股票授予情况 根据公司 2023 年度股东大会的授权，公司于 2025 年 4 月 29 日召开的第四届 董事会第八次会议、第四届监事会第四次会议审议通过了《关于调整公司 2024 年 限制性股票激励计划授予数量、向激励对象授予预留部分限制性股票的议案》，确 定以 2025 年 4 月 29 日为预留授予日，向符合授予条件的 49 名激励对象授予 30.16 万股限制性股票，授予价格为人民币 5.86 元/股。监事会对本次激励计划授予相 关事 ...